Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

[Overtreatment of localized prostate cancer in older men-do we need a new definition of clinical significance?]

Urologie (Heidelberg, Germany)·2026

Same author

Sexual Function and Libido Loss in Female Climbers-A Cross-Sectional Study.

Sports (Basel, Switzerland)·2026

Same author

Tumor anatomy predictors of mic and trifecta achievement in robot-assisted partial nephrectomy: a multicenter analysis stratified by PADUA score.

Journal of robotic surgery·2026

Same author

A cross-sectional study exploring mental health literacy among non-athlete personnel in elite-level road cycling.

Discover mental health·2026

Same author

Hemorrhage in Robot-assisted Partial Nephrectomy: A Multicentric, Retrospective Analysis of Blood Transfusion and Bleeding Requiring Intervention in 3726 Cases.

European urology open science·2026

Same author

Mortality Data Collection by Local Authorities Compared to a Cancer Registry.

Deutsches Arzteblatt international·2026

Search research articles

Related Experiment Video

Updated: Sep 13, 2025

An Orthotopic Murine Model of Human Prostate Cancer Metastasis

An Orthotopic Murine Model of Human Prostate Cancer Metastasis

Published on: September 18, 2013

Estimating Bone Metastasis Risk in Prostate Cancer: A Three-Parameter Model Using Bone Sialoprotein, ISUP Grading,

Christos Philippou¹, Simon Gloger², Burkhard Ubrig²

¹Institute of Pathology, Augusta-Hospital, Bochum, Germany, c.philippou@patho-augusta.de.

Urologia Internationalis

|July 27, 2025

Summary

This summary is machine-generated.

Bone sialoprotein (BSP) expression in prostate cancer biopsies can help predict bone metastasis. Integrating BSP with ISUP grade and biopsy data improves risk assessment accuracy for early detection.

Keywords:

Bone metastasis Bone sialoprotein Immunohistochemistry Prostate cancer

More Related Videos

Intra-Cardiac Injection of Human Prostate Cancer Cells to Create a Bone Metastasis Xenograft Mouse Model

Intra-Cardiac Injection of Human Prostate Cancer Cells to Create a Bone Metastasis Xenograft Mouse Model

Published on: November 4, 2022

Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone

Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone

Published on: September 9, 2020

Related Experiment Videos

Last Updated: Sep 13, 2025

An Orthotopic Murine Model of Human Prostate Cancer Metastasis

An Orthotopic Murine Model of Human Prostate Cancer Metastasis

Published on: September 18, 2013

Intra-Cardiac Injection of Human Prostate Cancer Cells to Create a Bone Metastasis Xenograft Mouse Model

Intra-Cardiac Injection of Human Prostate Cancer Cells to Create a Bone Metastasis Xenograft Mouse Model

Published on: November 4, 2022

Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone

Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone

Published on: September 9, 2020

Area of Science:

Oncology
Pathology
Biomarker Discovery

Background:

Prostate cancer commonly metastasizes to bone.
Predictive factors for bone metastasis include PSA levels, ISUP grade, and tumor progression.
A clinical scoring system for bone metastasis risk at diagnosis is lacking.

Purpose of the Study:

To investigate bone sialoprotein (BSP) expression in prostate cancer.
To determine the correlation between BSP expression and bone metastasis.
To develop a predictive model for bone metastasis risk.

Main Methods:

Immunohistochemistry evaluated BSP expression in prostate cancer biopsies.
Data from 673 patients were analyzed over a 7-9 year follow-up.
Multivariate logistic regression assessed BSP alongside established risk factors.

Main Results:

Bone metastases developed in 12.5% of patients.
Higher BSP expression correlated with bone metastasis (55.5% vs. 25.7%).
A three-parameter model (BSP, ISUP grade, biopsy data) achieved 88.6% sensitivity and 81.1% specificity.

Conclusions:

BSP expression is a potential indicator for bone metastasis but lacks standalone sensitivity.
Integrating BSP with ISUP grade and biopsy data significantly improves predictive accuracy.
BSP immunohistochemistry could enhance early risk stratification in prostate cancer.